{
    "pmcid": "8351461",
    "qa_pairs": {
        "How do the sdAbs B6 and C2 affect the biochemical properties of the N protein?": [
            "They reduce RNA binding and compromise phase separation",
            "They enhance RNA binding and promote phase separation",
            "They inhibit protein dimerization and increase phase separation",
            "They stabilize protein folding and decrease RNA binding"
        ],
        "What are the dissociation constants (Kd) range for the llama-derived single-domain antibodies targeting the SARS-CoV-2 N protein?": [
            "0.8-1.6 nM",
            "1.8-2.6 nM",
            "0.5-1.0 nM",
            "2.0-3.0 nM"
        ],
        "What is the primary structural feature used by sdAb-C2 to bind the N protein RBD?": [
            "Concave surface with a hydrophobic interface",
            "Flat surface with ionic interactions",
            "Convex surface with hydrogen bonds",
            "Grooved surface with van der Waals forces"
        ],
        "What makes the sdAbs suitable for widespread diagnostic use, particularly in resource-limited settings?": [
            "They can be produced in large quantities using bacterial expression systems",
            "They require complex mammalian cell expression systems",
            "They need high-cost purification processes",
            "They are unstable at room temperature"
        ],
        "Which domains of the SARS-CoV-2 N protein do the sdAbs B6 and C2 target?": [
            "N-terminal RNA-binding domain (RBD)",
            "C-terminal dimerization domain (CTD)",
            "Central linker region",
            "Membrane-associated domain"
        ]
    }
}